Systolic Heart failure treatment with the If inhibitor ivabradine Trial

被引:0
|
作者
不详
机构
关键词
PLACEBO-CONTROLLED TRIAL; CORONARY-ARTERY-DISEASE; CHRONIC STABLE ANGINA; DOUBLE-BLIND; DYSFUNCTION; BEAUTIFUL; EFFICACY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:519 / 522
页数:4
相关论文
共 50 条
  • [1] Ivabradine in Heart Failure The Representativeness of SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) in a Broad Population of Patients With Chronic Heart Failure
    Das, Debraj
    Savarese, Gianluigi
    Dahlstrom, Ulf
    Fu, Michael
    Howlett, Jonathan
    Ezekowitz, Justin A.
    Lund, Lars H.
    [J]. CIRCULATION-HEART FAILURE, 2017, 10 (09)
  • [2] SHIFT trial (Systolic Heart failure treatment with the I-f inhibitor ivabradine Trial) A SHIFT in the treatment of heart failure
    Perrone, Sergio V.
    [J]. INSUFICIENCIA CARDIACA, 2010, 5 (03) : 132 - 136
  • [3] Estimation of Decrements of Utility Associated With Hospitalizations in a Population With Heart Failure From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanimira
    Kansal, Anuraag R.
    Zheng, Ying
    Patel, Harshali K.
    Kielhorn, Adrian
    Bohm, Michael
    Tavazzi, Luigi
    Ford, Ian
    [J]. CIRCULATION, 2016, 134
  • [4] Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey S.
    Ford, Ian
    Tavazzi, Luigi
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (01) : 75 - 81
  • [5] Effect of Visit-to-Visit Variation of Heart Rate and Systolic Blood Pressure on Outcomes in Chronic Systolic Heart Failure: Results From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT) Trial
    Boehm, Michael
    Robertson, Michele
    Borer, Jeffrey
    Ford, Ian
    Komajda, Michel
    Mahfoud, Felix
    Ewen, Sebastian
    Swedberg, Karl
    Tavazzi, Luigi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (02):
  • [6] Effects of Heart Rate Reduction in Black Patients from the SHIFT (Systolic Heart Failure treatment with the If Inhibitor Ivabradine Trial) Study
    Borer, Jeffrey S.
    Komajda, Michel
    Ford, Ian
    Tavazzi, Luigi
    Dominjon, Fabienne
    Maya, Juan
    Wu, Yuna
    Depre, Christophe
    Boehm, Michael
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S45
  • [7] Ivabradine for systolic heart failure
    Meade, Courtney M.
    Clements, Jennifer N.
    [J]. JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (03): : 52 - 54
  • [8] BETA BLOCKER DOSAGE AND USE OVER TIME IN THE SYSTOLIC HEART FAILURE TREATMENT WITH THE IF INHIBITOR IVABRADINE TRIAL (SHIFT) STUDY
    Borer, Jeffrey S.
    Swedberg, Karl
    Komajda, Michel
    Ford, Ian
    Tavazzi, Luigi
    Boehm, Michael
    Dominjon, Fabienne
    Maya, Juan
    Wu, Yuna
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A872 - A872
  • [9] Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose? Findings From the SHIFT (Systolic Heart failure treatment with the If inhibitor ivabradine Trial) Study
    Swedberg, Karl
    Komajda, Michel
    Boehm, Michael
    Borer, Jeffrey
    Robertson, Michele
    Tavazzi, Luigi
    Ford, Ian
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (22) : 1938 - 1945
  • [10] Effect of Ivabradine on Readmission: A Post-Hoc Bayesian Analysis of 30-day Readmission Rates in the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanmira
    Kansal, Anuraag R.
    Ishak, K. Jack
    Kielhorn, Adrian
    Patel, Harshali
    Borer, Jeffery S.
    [J]. JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S107 - S107